Cargando…

Radiomic Analysis for Pretreatment Prediction of Recurrence Post-Radiotherapy in Cervical Squamous Cell Carcinoma Cancer

Background: The current study aims to predict the recurrence of cervical cancer patients treated with radiotherapy from radiomics features on pretreatment T1- and T2-weighted MR images. Methods: A total of 89 patients were split into model training (63 patients) and model testing (26 patients). The...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawahara, Daisuke, Nishibuchi, Ikuno, Kawamura, Masashi, Yoshida, Takahito, Koh, Iemasa, Tomono, Katsuyuki, Sekine, Masaki, Takahashi, Haruko, Kikuchi, Yutaka, Kudo, Yoshiki, Nagata, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600567/
https://www.ncbi.nlm.nih.gov/pubmed/36292034
http://dx.doi.org/10.3390/diagnostics12102346
_version_ 1784816875345018880
author Kawahara, Daisuke
Nishibuchi, Ikuno
Kawamura, Masashi
Yoshida, Takahito
Koh, Iemasa
Tomono, Katsuyuki
Sekine, Masaki
Takahashi, Haruko
Kikuchi, Yutaka
Kudo, Yoshiki
Nagata, Yasushi
author_facet Kawahara, Daisuke
Nishibuchi, Ikuno
Kawamura, Masashi
Yoshida, Takahito
Koh, Iemasa
Tomono, Katsuyuki
Sekine, Masaki
Takahashi, Haruko
Kikuchi, Yutaka
Kudo, Yoshiki
Nagata, Yasushi
author_sort Kawahara, Daisuke
collection PubMed
description Background: The current study aims to predict the recurrence of cervical cancer patients treated with radiotherapy from radiomics features on pretreatment T1- and T2-weighted MR images. Methods: A total of 89 patients were split into model training (63 patients) and model testing (26 patients). The predictors of recurrence were selected using the least absolute shrinkage and selection operator (LASSO) regression. The machine learning used neural network classifiers. Results: Using LASSO analysis of radiomics, we found 25 features from the T1-weighted and 4 features from T2-weighted MR images, respectively. The accuracy was highest with the combination of T1- and T2-weighted MR images. The model performances with T1- or T2-weighted MR images were 86.4% or 89.4% accuracy, 74.9% or 38.1% sensitivity, 81.8% or 72.2% specificity, and 0.89 or 0.69 of the area under the curve (AUC). The model performance with the combination of T1- and T2-weighted MR images was 93.1% accuracy, 81.6% sensitivity, 88.7% specificity, and 0.94 of AUC. Conclusions: The radiomics analysis with T1- and T2-weighted MR images could highly predict the recurrence of cervix cancer after radiotherapy. The variation of the distribution and the difference in the pixel number at the peripheral and the center were important predictors.
format Online
Article
Text
id pubmed-9600567
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96005672022-10-27 Radiomic Analysis for Pretreatment Prediction of Recurrence Post-Radiotherapy in Cervical Squamous Cell Carcinoma Cancer Kawahara, Daisuke Nishibuchi, Ikuno Kawamura, Masashi Yoshida, Takahito Koh, Iemasa Tomono, Katsuyuki Sekine, Masaki Takahashi, Haruko Kikuchi, Yutaka Kudo, Yoshiki Nagata, Yasushi Diagnostics (Basel) Article Background: The current study aims to predict the recurrence of cervical cancer patients treated with radiotherapy from radiomics features on pretreatment T1- and T2-weighted MR images. Methods: A total of 89 patients were split into model training (63 patients) and model testing (26 patients). The predictors of recurrence were selected using the least absolute shrinkage and selection operator (LASSO) regression. The machine learning used neural network classifiers. Results: Using LASSO analysis of radiomics, we found 25 features from the T1-weighted and 4 features from T2-weighted MR images, respectively. The accuracy was highest with the combination of T1- and T2-weighted MR images. The model performances with T1- or T2-weighted MR images were 86.4% or 89.4% accuracy, 74.9% or 38.1% sensitivity, 81.8% or 72.2% specificity, and 0.89 or 0.69 of the area under the curve (AUC). The model performance with the combination of T1- and T2-weighted MR images was 93.1% accuracy, 81.6% sensitivity, 88.7% specificity, and 0.94 of AUC. Conclusions: The radiomics analysis with T1- and T2-weighted MR images could highly predict the recurrence of cervix cancer after radiotherapy. The variation of the distribution and the difference in the pixel number at the peripheral and the center were important predictors. MDPI 2022-09-28 /pmc/articles/PMC9600567/ /pubmed/36292034 http://dx.doi.org/10.3390/diagnostics12102346 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kawahara, Daisuke
Nishibuchi, Ikuno
Kawamura, Masashi
Yoshida, Takahito
Koh, Iemasa
Tomono, Katsuyuki
Sekine, Masaki
Takahashi, Haruko
Kikuchi, Yutaka
Kudo, Yoshiki
Nagata, Yasushi
Radiomic Analysis for Pretreatment Prediction of Recurrence Post-Radiotherapy in Cervical Squamous Cell Carcinoma Cancer
title Radiomic Analysis for Pretreatment Prediction of Recurrence Post-Radiotherapy in Cervical Squamous Cell Carcinoma Cancer
title_full Radiomic Analysis for Pretreatment Prediction of Recurrence Post-Radiotherapy in Cervical Squamous Cell Carcinoma Cancer
title_fullStr Radiomic Analysis for Pretreatment Prediction of Recurrence Post-Radiotherapy in Cervical Squamous Cell Carcinoma Cancer
title_full_unstemmed Radiomic Analysis for Pretreatment Prediction of Recurrence Post-Radiotherapy in Cervical Squamous Cell Carcinoma Cancer
title_short Radiomic Analysis for Pretreatment Prediction of Recurrence Post-Radiotherapy in Cervical Squamous Cell Carcinoma Cancer
title_sort radiomic analysis for pretreatment prediction of recurrence post-radiotherapy in cervical squamous cell carcinoma cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600567/
https://www.ncbi.nlm.nih.gov/pubmed/36292034
http://dx.doi.org/10.3390/diagnostics12102346
work_keys_str_mv AT kawaharadaisuke radiomicanalysisforpretreatmentpredictionofrecurrencepostradiotherapyincervicalsquamouscellcarcinomacancer
AT nishibuchiikuno radiomicanalysisforpretreatmentpredictionofrecurrencepostradiotherapyincervicalsquamouscellcarcinomacancer
AT kawamuramasashi radiomicanalysisforpretreatmentpredictionofrecurrencepostradiotherapyincervicalsquamouscellcarcinomacancer
AT yoshidatakahito radiomicanalysisforpretreatmentpredictionofrecurrencepostradiotherapyincervicalsquamouscellcarcinomacancer
AT kohiemasa radiomicanalysisforpretreatmentpredictionofrecurrencepostradiotherapyincervicalsquamouscellcarcinomacancer
AT tomonokatsuyuki radiomicanalysisforpretreatmentpredictionofrecurrencepostradiotherapyincervicalsquamouscellcarcinomacancer
AT sekinemasaki radiomicanalysisforpretreatmentpredictionofrecurrencepostradiotherapyincervicalsquamouscellcarcinomacancer
AT takahashiharuko radiomicanalysisforpretreatmentpredictionofrecurrencepostradiotherapyincervicalsquamouscellcarcinomacancer
AT kikuchiyutaka radiomicanalysisforpretreatmentpredictionofrecurrencepostradiotherapyincervicalsquamouscellcarcinomacancer
AT kudoyoshiki radiomicanalysisforpretreatmentpredictionofrecurrencepostradiotherapyincervicalsquamouscellcarcinomacancer
AT nagatayasushi radiomicanalysisforpretreatmentpredictionofrecurrencepostradiotherapyincervicalsquamouscellcarcinomacancer